Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Cygnus XL brings cargo to the ISS for 1st time | Space photo of the day for Dec. 1, 2025 - 2Pick Your Favored kind of sandwich
- 3Israel strikes south Lebanon after first direct talks in decades
- 4In wrangling dark matter, some scientists find inspiration in the Torah, Krishna and Christ
- 5Guns N' Roses 2026 Tour: How to get tickets, presale times, prices and more
- Fears of global aluminum shortages intensify
- How Mars 'punches above its weight' to influence Earth's climate
- HGV driver recruited others to smuggle migrants
- Share your number one city visit transport that leaves a mark on the world wake up!
- Study reveals links between global food systems, obesity, and climate change
- U.S. to drop childhood vaccine recommendations as it looks to Denmark, Washington Post reports
- Old age isn’t a modern phenomenon – many people lived long enough to grow old in the olden days, too
- Select Your Go-To Bluetooth Earphones
- Alleged Huione Group Money Laundering Boss Extradited to China
